Visilizumab

Tax included
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research.
MedChemExpress 
HY-P99332

Data sheet

Size
Multiple sizes
Reactivity
Apoptosis
Application
COVID-19-immunoregulation
CAS
219716-33-3